SARS‐CoV‐2 mRNA vaccine injection site pseudolymphoma

Dillon Mintoff(University of Malta), Alexandra Betts(Mater Dei Hospital), L. Scerri(Mater Dei Hospital)
Journal of the European Academy of Dermatology and Venereology
September 21, 2021
10.1111/jdv.17680
Cited by 10

Related Papers

Psoriasis: Keratinocytes or Immune Cells – Which Is the Trigger?
|Dermatology|2018|227
Psoriasis and Microbiota: A Systematic Review
|Diseases|2018|135
The Genomic Architecture of Hidradenitis Suppurativa—A Systematic Review
|Frontiers in Genetics|2022|117
EULAR study group on ‘MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders
|Annals of the Rheumatic Diseases|2023|79
Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects
|International Journal of Dermatology|2021|57